Cite
HARVARD Citation
Vivar, O. et al. (n.d.). PH-0053 NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in advanced cancers: phase I trial. Radiotherapy and oncology. pp. S28-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vivar, O. et al. (n.d.). PH-0053 NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in advanced cancers: phase I trial. Radiotherapy and oncology. pp. S28-. [Online].